Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Regular physical activity reduces breast cancer risk irrespective of age

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Regular physical activity reduces breast cancer risk irrespective of age ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
31 Mar 2014

Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes

Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )
31 Mar 2014

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014

Immuno-biological properties of human cancer stem cells

Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy
Immuno-biological properties of human cancer stem cells ( Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy )
24 Mar 2014

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014

Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France
Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation ( Dr Rafael Sanchez-Salas - Institut Mutualiste Montsouris, Paris, France )
1 Feb 2014

ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases

Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014

Results of the MARS study in renal cell carcinoma

Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France
Results of the MARS study in renal cell carcinoma ( Dr Vincent Launay-Vacher - Pitie-Salpetriere Hospital, Paris, France )
31 Jan 2014

Dissecting the biology of the androgen receptor pathway

Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA
Dissecting the biology of the androgen receptor pathway ( Dr Peter Nelson - Fred Hutchinson Cancer Research Center, Seattle, USA )
30 Jan 2014

Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)

Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014